Cited by 16Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Research TopicsTreatment of Major Depression

Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study

Open access
Trombello, Joseph M., Pizzagalli, Diego A., Weissman, Myrna M., Grannemann, Bruce D., Cooper, Crystal M., Greer, Tracy L., Malchow, Ashley L., Jha, Manish K. +11 more·2018·Journal of Psychiatric Research

Abstract

The current study aimed to characterize the multifaceted nature of anxiety in patients with major depression by evaluating distinct anxiety factors. We then related these derived anxiety factors to performance on a Flanker Task of cognitive control, in order to further validate these factors. Data were collected from 195 patients with nonpsychotic chronic or recurrent major depression or dysthymic disorder. At baseline, participants completed self-report measures of anxiety, depression, and other related symptoms (mania, suicidality) and clinicians administered a structured diagnostic interview and the Hamilton Rating Scale for Depression, including anxiety/somatization items. Four discrete factors (State Anxiety, Panic, Neuroticism/Worry, and Restlessness/Agitation) emerged, with high degrees of internal consistency. Discriminant and convergent validity analyses also yielded findings in the expected direction. Furthermore, the neuroticism/worry factor was associated with Flanker Task interference, such that individuals higher on neuroticism/worry responded more incorrectly (yet faster) to incongruent vs. congruent trials whereas individuals higher on the fear/panic factor responded more slowly, with no accuracy effect, to the Flanker Task stimuli. These results parse anxiety into four distinct factors that encompass physiological, psychological, and cognitive components of anxiety. While state anxiety, panic and neuroticism/worry are related to existing measures of anxiety, the Restlessness/Agitation factor appears to be a unique measure of general anxious arousal. Furthermore, two factors were independently validated through the Flanker Task. These results suggest that these anxiety domains have distinct behavioral profiles and could have differential responses to distinct treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpsychires.2018.04.003

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. First MBS, L. R, Gibbson M, & Williams JBW, 2002 Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen Biometrics Research, New York State Psychiatric Institute New York.
  2. Nunnally JC, Bernstein IH, 1994 Psychometric Theory, 3rd Edition ed. McGraw-Hill, New York, NY.

Cited by

Sorted by citations

Authors
Trombello, J. M., Pizzagalli, D. A., Weissman, M. M., Grannemann, B. D., Cooper, C. M., Greer, T. L., Malchow, A. L., Jha, M. K., Carmody, T. J., Kurian, B. T., Webb, C. A., Dillon, D. G., McGrath, P. J., Bruder, G., Fava, M., Parsey, R. V., McInnis, M. G., Adams, P., & Trivedi, M. H.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Harvard University (US)
  • New York State Psychiatric Institute (US)
  • Stony Brook University (US)
  • University of Michigan (US)
Corresponding author
Trivedi, Madhukar H.
Venue
Journal of Psychiatric Research
Publisher
Elsevier BV
Published
2018-07
Volume
102
Pages
207-215
ISSN
0022-3956 (ISSN-L)
OpenAlex
W2796276840
Cited by
16
References
35
Citations by year
2026: 1 · 2025: 4 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Journal of Psychiatric Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Columbia Academic Commons (Columbia University)
Funders
  • National Institute of Mental Health of the National Institutes of Health (U01MH092221, U01MH092250)
  • EMBARC National Coordinating Center
  • Targacept, Inc
  • Pfizer, Inc
  • Johnson & Johnson
  • Evotec
  • Rexahn
  • Naurex
  • Forest Pharmaceuticals
  • National Institute of Mental Health
  • New York State Department of Mental Hygiene
  • Research Foundation for Mental Hygiene
  • Forest Research Laboratories
  • Sunovion Pharmaceuticals, and Naurex Pharmaceuticals
  • Abbott Laboratories
  • Acadia Pharmaceuticals
  • Alkermes, Inc
  • American Cyanamid
  • Aspect Medical Systems
  • AstraZeneca
  • Avanir Pharmaceuticals
  • AXSOME Therapeutics
  • BioResearch
  • BrainCells Inc
  • Bristol-Myers Squibb
  • CeNeRx BioPharma
  • Cephalon
  • Cerecor
  • Clintara, LLC
  • Covance
  • Covidien
  • Eli Lilly and Company
  • EnVivo Pharmaceuticals, Inc
  • Euthymics Bioscience, Inc
  • Forest Pharmaceuticals, Inc
  • FORUM Pharmaceuticals
  • Ganeden Biotech, Inc
  • GlaxoSmithKline
  • Harvard Clinical Research Institute
  • Hoffman-LaRoche
  • Icon Clinical Research
  • i3 Innovus/Ingenix
  • Janssen R&D, LLC
  • Jed Foundation
  • Johnson & Johnson Pharmaceutical Research & Development
  • Lichtwer Pharma GmbH
  • Lorex Pharmaceuticals
  • Lundbeck Inc
  • MedAvante
  • Methylation Sciences Inc
  • National Alliance for Research on Schizophrenia & Depression
  • National Center for Complementary and Alternative Medicine
  • National Coordinating Center for Integrated Medicine
  • National Institute of Drug Abuse
  • Neuralstem, Inc
  • NeuroRx
  • Novartis AG
  • Organon Pharmaceuticals
  • PamLab, LLC
  • Pfizer Inc
  • Pharmacia-Upjohn
  • Pharmaceutical Research Associates., Inc
  • Pharmavite® LLC
  • PharmoRx Therapeutics
  • Photothera
  • Reckitt Benckiser
  • Roche Pharmaceuticals
  • RCT Logic, LLC
  • Sanofi-Aventis US LLC
  • Shire
  • Solvay Pharmaceuticals, Inc
  • Stanley Medical Research Institute
  • Synthelabo
  • Takeda Pharmaceuticals
  • Tal Medical
  • Wyeth-Ayerst Laboratories
  • Adamed, Co
  • Advanced Meeting Partners
  • American Psychiatric Association;
  • American Society of Clinical Psychopharmacology
  • Belvoir Media Group
  • Boehringer Ingelheim GmbH
  • Cephalon, Inc
  • CME Institute/Physicians Postgraduate Press, Inc
  • Imedex, LLC
  • MGH Psychiatry Academy/Primedia
  • MGH Psychiatry Academy/Reed Elsevier
  • PharmaStar
  • United BioSource,Corp
  • National Institute on Drug Abuse
  • National Alliance for Research on Schizophrenia and Depression
  • Sackler Foundation
  • Templeton Foundation
  • Abbott Laboratories Inc
  • Akzo
  • Allergan Sales LLC
  • Alkermes, Arcadia Pharmaceuticals Inc
  • Axon Advisors, Brintellix
  • Bristol-Myers Squibb Company
  • Cephalon Inc
  • Eli Lilly & Company
  • Fabre Kramer Pharmaceuticals Inc
  • Global Medical Education Inc
  • Health Research Associates
  • Lundbeck, MedAvante Medscape
  • Medtronic, Merck, Mitsubishi Tanabe Pharma Development America Inc
  • MSI Methylation Sciences Inc
  • Nestle Health Science-PamLab Inc
  • Naurex, Neuronetics, One Carbon Therapeutics Ltd
  • Otsuka Pharmaceuticals, Pamlab, Parke-Davis Pharmaceuticals Inc
  • PgxHealth
  • Phoenix Marketing Solutions
  • Rexahn Pharmaceuticals
  • Ridge Diagnostics
  • Roche Products Ltd
  • Sepracor
  • SHIRE Development
  • Sierra, SK Life and Science
  • Sunovion, Takeda
  • Tal Medical/Puretech Venture
  • Targacept, Transcept, VantagePoint, Vivus, and Wyeth-Ayerst Laboratories
  • Agency for Healthcare Research and Quality
  • Cyberonics Inc
  • National Alliance for Research in Schizophrenia and Depression
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
anxiety subtypes, major depressive disorder, dysthymia, state anxiety, panic, flanker task, cognitive control, anxiety factors
MeSH terms
Neuroticism, Adult, Antidepressive Agents, Anxiety, Major Depressive Disorder, Depressive Disorder, Major, Electroencephalography, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Psychiatric Status Rating Scales, Psychometrics, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review